Education
About Us
Working with TipRanks
Follow Us
Invion Ltd. (AU:IVX)
:IVX
IVX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.43
Previous CloseN/A
Volume36.17K
Average Volume (3M)137.78K
Market Cap
AU$10.59M
Enterprise ValueAU$1.10B
Total Cash (Recent Filing)AU$736.45K
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.41
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding84,728,660
10 Day Avg. Volume125,192
30 Day Avg. Volume137,782
Financial Highlights & Ratios
PEG Ratio31.80
Price to Book (P/B)69.79
Price to Sales (P/S)0.00
P/FCF Ratio-292.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Invion News
PremiumCompany Announcements
Invion Limited Announces Pro Rata Issue of Loyalty Options
PremiumCompany Announcements
Invion Limited Announces $1 Million Entitlement Offer
PremiumCompany Announcements
Invion Announces $1 Million Entitlement Offer for Eligible Shareholders
PremiumCompany Announcements
Invion Limited Announces Entitlement Offer to Raise $1 MillionPremiumCompany Announcements
Invion Announces Fully Underwritten Loyalty Option Entitlement Offer
PremiumCompany Announcements
Invion Launches Loyalty Option Offer to Fund Clinical Trials
PremiumCompany Announcements
Invion Reports Positive Trial Results for Skin Cancer Treatment
PremiumCompany Announcements
Invion Unveils New Presentation on Innovative Cancer Treatment TechnologyIVX FAQ
What was Invion Ltd.’s price range in the past 12 months?
Invion Ltd. lowest share price was AU$0.08 and its highest was AU$0.43 in the past 12 months.
What is Invion Ltd.’s market cap?
Invion Ltd.’s market cap is AU$10.59M.
When is Invion Ltd.’s upcoming earnings report date?
Invion Ltd.’s upcoming earnings report date is Aug 29, 2025 which is in 67 days.
How were Invion Ltd.’s earnings last quarter?
Invion Ltd. released its earnings results on Feb 28, 2025. The company reported -AU$0.028 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.028.
Is Invion Ltd. overvalued?
According to Wall Street analysts Invion Ltd.’s price is currently Overvalued.
Does Invion Ltd. pay dividends?
Invion Ltd. does not currently pay dividends.
What is Invion Ltd.’s EPS estimate?
Invion Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invion Ltd. have?
Invion Ltd. has 84,728,660 shares outstanding.
What happened to Invion Ltd.’s price movement after its last earnings report?
Invion Ltd. reported an EPS of -AU$0.028 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Invion Ltd.?
Currently, no hedge funds are holding shares in AU:IVX
Invion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IVX Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.00%
12-Months-Change
Fundamentals
Return on Equity
-44.03%
Trailing 12-Months
Asset Growth
-31.52%
Trailing 12-Months
Company Description
Invion Ltd.
Invion (IVX) is a biotechnology company focused on the research, development, and commercialization of Photodynamic Therapy (PDT) for the treatment of various cancers. Operating primarily in the healthcare and pharmaceutical sectors, Invion is dedicated to advancing its novel technologies to offer innovative treatment solutions that can improve patient outcomes. The company's core products include its proprietary PDT compounds and related systems that leverage light-activated processes to target and destroy cancer cells.